Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  La Jolla Pharmaceutical Company    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

LA JOLLA PHARMACEUTICAL COMPANY : REVERSE SPLIT: 1 for 50

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/14/2014 CEST
REVERSE SPLIT: 1 for 50


© Factset 2014
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LA JOLLA PHARMACEUTICAL CO
06:41p LA JOLLA PHARMACEUTICAL COMPANY : Announces Intent to Submit Marketing Authoriza..
05:36p LA JOLLA PHARMACEUTICAL : Announces Intent to Submit Marketing Authorization App..
09/20 LA JOLLA PHARMACEUTICAL : Prespecified Analysis of ATHOS-3 Indicates Survival Be..
09/20 LA JOLLA PHARMACEUTICAL : Prespecified Analysis of ATHOS-3 Indicates Survival Be..
09/07 LA JOLLA PHARMACEUTICAL COMPANY (NAS : LJPC) Files An 8-K Departure of Directors..
09/06 LA JOLLA PHARMACEUTICAL CO : Change in Directors or Principal Officers, Submissi..
08/31 LA JOLLA PHARMACEUTICAL COMPANY : Announces U.S. FDA Acceptance of New Drug Appl..
08/29 LA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (fo..
08/28 LA JOLLA PHARMACEUTICAL COMPANY : Announces U.S. FDA Acceptance of New Drug Appl..
08/17 LA JOLLA PHARMACEUTICAL COMPANY : Announces Launch of Expanded Access Program fo..
More news
Financials ($)
Sales 2017 -
EBIT 2017 -108 M
Net income 2017 -112 M
Finance 2017 88,0 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 0
EV / Sales 2018 22,9x
Capitalization 823 M
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 55,4 $
Spread / Average Target 49%
EPS Revisions
Managers
NameTitle
George Francis Tidmarsh President, CEO, Secretary & Director
Kevin C. Tang Chairman
Jennifer Carver Chief Operating Officer
Dennis M. Mulroy Chief Financial & Accounting Officers
Lakhmir S. Chawla Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
LA JOLLA PHARMACEUTICAL COMPANY823
AMGEN27.65%135 544
CELGENE CORPORATION24.22%112 572
GILEAD SCIENCES15.37%108 744
REGENERON PHARMACEUTICALS18.08%46 367
VERTEX PHARMACEUTICALS106.41%38 136